Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 18, 2011 - Issue 3
165
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis

, , , &
Pages 108-111 | Published online: 01 Jun 2011
 

Abstract

Objective. Acceleration of amyloid A (AA) amyloidosis induction by ageing has not been extensively studied in rheumatoid arthritis (RA). The aim of this study is to clarify contribution of ageing to the development of AA amyloidosis associated with RA in our large cohort.

Methods. 388 adult-onset RA patients whose RA was complicated by biopsy-proven AA amyloidosis were enrolled. The ages of RA onset and AA amyloidosis diagnosis were estimated in each patient. The contributions of ageing, inflammatory activity, SAA1 exon 3 polymorphism as well as gender to the pathogenesis of AA amyloidosis in 144 cases were also studied by multiple regression analysis.

Results. Subjects with RA onset at older age had a shorter period to develop amyloidosis than those with disease onset at younger age (p < 0.001). The interval between RA onset and AA amyloidosis diagnosis was significantly shorter in the SAA1.3 positive group than in the SAA1.3 negative (p = 0.001). Multiple regression analysis indicated that the interval from RA onset to diagnosis of AA amyloidosis is determined by age at RA onset (p < 0.001), the most recent median annual CRP concentration (p = 0.006) and SAA1.3 allele (p = 0.058). Gender did not significantly contribute to the onset of AA amyloidosis (p = 0.569).

Conclusion. Ageing is an independent risk factor for the induction of AA amyloidosis complicating RA.

Acknowledgements

We thank our colleagues for referring and caring for the patients; Onishi M, Matoba K, Jouyama K, Yamada A, Takebayashi M, Sawada N, Mokuda S at Dohgo Spa Hospital. We also thank George A Goldberg M.D for looking over and correcting English.

Declaration of interest: This work was supported by a grant from the Intractable Disease Division of the Ministry of Health and Welfare of Japan, a Research Committee for Amyloidosis in Japan.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.